Combined oral protocol for GI applications: BPC-157: 250 to 500 mcg orally, once daily, on an empty stomach KPV: 500 to 1,000 mcg orally, once or twice daily Cycle: 6 to 8 weeks of both compounds simultaneously, then 4 weeks off Both can be taken in the same oral dose, dissolved in water or in capsule form Adding GHK-Cu (advanced stack): GHK-Cu: 1 mg subcutaneously, 2 to 3 times per week Provides collagen and mucosal integrity support while BPC-157 and KPV drive repair and inflammation control How to Choose the Right Gut Health Peptide Gastric ulcer or upper GI inflammation: BPC-157 oral is the primary recommendation
Mid-Phase: 375 mcg daily during Weeks 58
Buffers containing strong chelators (EDTA, EGTA) or reducing agents (DTT, -mercaptoethanol, TCEP) should be avoided at the reconstitution step, since chelators can strip copper from the GHK-Cu component
Conclusion The research peptide market has gone through a lot of changes in recent years
Your health is our top priority, and our team is committed to guiding you through every step of your wellness journey
Potential risks include breast tenderness, headaches, slight increase in breast cancer risk with prolonged synthetic progestin use (not seen with micronized progesterone), blood clot risk with oral estrogen (not transdermal), and gallbladder disease risk with oral estrogen